[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,458,283
  • Shares Outstanding, K 58,734
  • Annual Sales, $ 507,440 K
  • Annual Income, $ -187,690 K
  • EBIT $ -86 M
  • EBITDA $ -47 M
  • 60-Month Beta 0.94
  • Price/Sales 16.45
  • Price/Cash Flow N/A
  • Price/Book 12.44

Options Overview Details

View History
  • Implied Volatility 46.76% (-1.01%)
  • Historical Volatility 64.76%
  • IV Percentile 24%
  • IV Rank 22.57%
  • IV High 76.55% on 10/21/25
  • IV Low 38.07% on 08/12/25
  • Expected Move (DTE 33) 17.32 (12.03%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 55
  • Volume Avg (30-Day) 83
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 1,776
  • Open Int (30-Day) 1,223
  • Expected Range 126.69 to 161.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.27
  • Number of Estimates 5
  • High Estimate $-0.24
  • Low Estimate $-0.31
  • Prior Year $-0.24
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.00 +27.44%
on 04/29/26
146.75 -1.87%
on 05/01/26
+23.01 (+19.02%)
since 04/15/26
3-Month
95.87 +50.21%
on 03/13/26
146.75 -1.87%
on 05/01/26
+34.54 (+31.55%)
since 02/13/26
52-Week
73.16 +96.84%
on 10/28/25
146.75 -1.87%
on 05/01/26
+52.39 (+57.18%)
since 05/15/25

Most Recent Stories

More News
Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 144.01 (+1.31%)
Glaukos: Q1 Earnings Snapshot

Glaukos: Q1 Earnings Snapshot

GKOS : 144.01 (+1.31%)
Glaukos Announces First Quarter 2026 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 144.01 (+1.31%)
Glaukos Reports Tomorrow With Epioxa Launch Metrics Still Unknown

Barchart Research What to Expect from GKOS Earnings GKOS Generated April 28, 2026 Current Price $119.63 EPS Estimate $$-0.30 Consensus Rating Strong Buy Average Move 9.55% Glaukos Reports Tomorrow With...

GKOS : 144.01 (+1.31%)
Glaukos Announces the Release of its 2025 Sustainability Report

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 144.01 (+1.31%)
Glaukos Receives Permanent J-code for Epioxaâ„¢

New J-code for Epioxa â„¢ , J2789, set to become effective July 1, 2026

GKOS : 144.01 (+1.31%)
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 144.01 (+1.31%)
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced...

GKOS : 144.01 (+1.31%)
Glaukos Announces Commercial Availability of Epioxaâ„¢, a Transformative Innovation in Interventional Keratoconus Care

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare Disease

GKOS : 144.01 (+1.31%)
Glaukos: Q4 Earnings Snapshot

Glaukos: Q4 Earnings Snapshot

GKOS : 144.01 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 148.39
2nd Resistance Point 146.28
1st Resistance Point 145.14
Last Price 144.01
1st Support Level 141.89
2nd Support Level 139.78
3rd Support Level 138.64

See More

52-Week High 146.75
Last Price 144.01
Fibonacci 61.8% 118.64
Fibonacci 50% 109.96
Fibonacci 38.2% 101.27
52-Week Low 73.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.